What is a biological virus
What is a biological virus
Two examples of virus structure. Both have a protein coat on the outside
Article
From influenza to polio, from dengue to encephalitis, from Ebola to hanta, viruses are the most deadly challenges humans face. And there are uncountable numbers of viruses, most of which we don’t know about. J. Craig Venter, who decoded the human genome, has genetically sequenced 10,000 or so of them. When he sailed his yacht, Sorcerer II, around the world in 2005 and 2006, he stopped every so often to take samples of seawater and then studied what was in them. He found that 1 tablespoon of ocean water contains billions of previously unknown viruses.
Viruses are weird. They are unlike any other self-replicating form that we call life. They have no nucleus and no outer membrane, and they’re tiny — about 1% the size of a single bacterium. They cannot reproduce by themselves, and instead must invade a normal cell and rearrange the molecules they find inside to assemble more versions of them. In the process, they typically kill the cell by exploding its membrane, which is how they kill humans: one cell at a time. But viruses are like cells in that they have genes and can evolve.
The human immune system is good at identifying viruses and killing them by developing antibodies that bind to the viruses and keep them from reproducing, which is why vaccines work. Vaccines educate the immune system about a specific virus and set up the antibody process. Sometimes a vaccine can be as simple as injecting dead viruses into a human so the immune system can build antibodies against it. Killer T cells in the human immune system can identify a virus on a host cell and kill the cell to prevent the virus from replicating.
DNA viruses are very tough to eradicate permanently. They can become latent, maintaining a constant war with the immune system. Chickenpox, Epstein-Barr, shingles and herpes cold sore viruses can “hide” effectively in a human body for decades.
Medicine has almost nothing to fight viruses. A few approved anti-virus drugs have been developed in recent years, but most are not reliably effective, and even then only against a very narrow range of viruses. Antibiotics actually kill bacteria, but anti-viral drugs usually only keep the virus from reproducing or spreading too fast to overwhelm the body.
But several companies have promising antiviral drugs in the works. Gilead Sciences launched Sovaldi in December 2013, and it actually cures hepatitis C in almost all cases. It is not a broad-spectrum anti-viral. There are anti-viral drugs to tackle some flu bugs and herpes, but they don’t work reliably. A “cocktail” of anti-virals can keep HIV at bay for a while.
The most interesting anti-viral drugs in development come from a Raleigh, N.C., company called Chimerix. The company has a broad spectrum antiviral drug called bincidofovir now in a large Phase 3 trial.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...
Continue Reading
Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...
Continue Reading
Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...
Continue Reading
Seismic Merger: Reliable Sprinkler and ASC Join Forces When two companies with roots stretching back to the 1800s decide to merge, it's not just a business move—it's a bold statement. Reliable Automatic Sprinkler and ASC Engineered Solutions, with over 175 years of combined innovation, have officially become Reliable Safety & Flow Corporation. This ain't just a...
Continue Reading
High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...
Continue Reading
Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...
Continue Reading
A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...
Continue Reading
Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...
Continue Reading
The Plot Thickens with Innventure's DarkNX Project Buckle up, fellow market sling-riders; the Innventure tale is a rocky one for the books. Imagine this: You’ve plunked down your hard-earned cash on Innventure Inc. (NASDAQ: INV), lured by their glowing pronouncements about a supposed golden egg project, the Accelsius DarkNX data-center deal. A big talk about...
Continue Reading
Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...
Continue Reading
Top 5 Most Recently Viewed Articles
Dataiku Welcomes a New Leader to Its Board Dataiku, a prominent player in the artificial intelligence space, has announced an exciting new addition to its Board of Directors. Alexandre Dayon, who previously held the role of President at Salesforce, will be joining the board to serve as Chair of the Compensation Committee. This strategic appointment comes at a critical...
Continue Reading
As Hurricane Helene barrels toward the Gulf Coast, the energy sector is bracing for impact like never before. This isn't just another storm; it’s a Category 4 monster in the making that promises catastrophic winds and surging waters. The scene is set: energy facilities along the coast are already shutting down operations and scrambling to get personnel to safety....
Continue Reading
NVIDIA: Strategies to Navigate the Seasonal Downturn Effectively NVIDIA (NASDAQ: NVDA) has found itself returning to its recent lows, experiencing a decline of more than 16% in a week. Investors are left pondering what measures can effectively halt this downturn. The latest factors contributing to the slide of NVIDIA’s stock include speculations regarding potential...
Continue Reading
Coty Inc's Stock Upgrade and Market Potential Recently, Coty Inc. (NYSE: COTY), a global player in the beauty industry, received an upgrade from Jefferies, transitioning from a Hold to a Buy rating. This upgrade comes with a new price target set at $12.00, a step up from the previous $11.00. Investors are buzzing about this positive shift, intrigued by the company's...
Continue Reading
Costco's Fourth Quarter Earnings Overview Costco Wholesale Corp (NASDAQ: COST) recently shared its fourth-quarter financial results, sharing some significant updates after the market closed. These results reflect the company’s operations and performance during the quarter, and they offer valuable insights for investors and analysts alike. Revenue Report and Analyst...
Continue Reading